Table 2.
CSF marker | median (range) | reference cut-off* |
NSE (n = 57) | 70 (9–200) ng/ml | 12.5 ng/ml |
tau (n = 56) | 6764 (3772–27770) pg/ml | 195 pg/ml |
phosphorylated tau (n = 33) | 55 (18.4–138) pg/ml | 61 pg/ml |
14-3-3 (n = 51) | 984 (410–5387) ng/ml | 200 ng/ml |
S 100b (n = 54) | 8 (1.4–39.2) ng/ml | 2 ng/ml |
PrP (n = 45) | 15.7 (1–40.9) ng/100ml | 22 ng/100ml |
Aβ1–42 | 467 (143–959) pg/ml | 849 pg/ml |
*: data were taken according to the manufacturers instruction in cases where commercially developed kits are available, otherwise calculated based on results from non-neurological controls from our study (14-3-3 and PrP)